sapropterin dipharma
dipharma arzneimittel gmbh - sapropterin-dihydrochloridu - fenylketonurie - jiné zažívací trakt a produkty metabolismu, - sapropterin dipharma is indicated for the treatment of hyperphenylalaninaemia (hpa) in adults and paediatric patients of all ages with phenylketonuria (pku) who have been shown to be responsive to such treatment. sapropterin dipharma is also indicated for the treatment of hyperphenylalaninaemia (hpa) in adults and paediatric patients of all ages with tetrahydrobiopterin (bh4) deficiency who have been shown to be responsive to such treatment.
dasatinib accordpharma
accord healthcare s.l.u. - dasatinib - precursor cell lymphoblastic leukemia-lymphoma; leukemia, myelogenous, chronic, bcr-abl positive - antineoplastická činidla - dasatinib accordpharma is indicated for the treatment of adult patients with: newly diagnosed philadelphia chromosome positive (ph+) chronic myelogenous leukaemia (cml) in the chronic phase. chronic, accelerated or blast phase cml with resistance or intolerance to prior therapy including imatinib. ph+ acute lymphoblastic leukaemia (all) and lymphoid blast cml with resistance or intolerance to prior therapy. dasatinib accordpharma is indicated for the treatment of paediatric patients with: newly diagnosed ph+ cml in chronic phase (ph+ cml-cp) or ph+ cml-cp resistant or intolerant to prior therapy including imatinib. newly diagnosed ph+ all in combination with chemotherapy.
aripiprazole mylan pharma (previously aripiprazole pharmathen)
mylan pharmaceuticals limited - aripiprazol - schizophrenia; bipolar disorder - psycholeptika - aripiprazol mylan pharma je určen k léčbě schizofrenie u dospělých a dospívajících ve věku 15 let a starších. aripiprazole mylan pharma je indikován k léčbě středně těžkých až těžkých manických epizod u bipolární poruchy i a k prevenci nových manických epizod u dospělých, u kterých se již převážně manické epizody vyskytly a jejichž manické epizody odpověděl léčba aripiprazolem byla účinná. aripiprazole mylan pharma je indikován k léčbě až 12 týdnů, středně těžké až těžké manické epizody u bipolární poruchy i u dospívajících ve věku 13 let a starší.
irinotecan accordpharma 20mg/ml koncentrát pro infuzní roztok
accord healthcare polska sp. z o.o., varšava array - 14658 trihydrÁt irinotekan-hydrochloridu - koncentrát pro infuzní roztok - 20mg/ml - irinotekan
tenofovir disoproxil accordpharma 245mg potahovaná tableta
accord healthcare polska sp. z o.o., varšava array - 16950 tenofovir-disoproxil-fumarÁt - potahovaná tableta - 245mg - tenofovir-disoproxil
clopidogrel taw pharma (previously clopidogrel mylan)
taw pharma (ireland) limited - hydrochlorid klopidogrelu - peripheral vascular diseases; stroke; myocardial infarction; acute coronary syndrome - antitrombotické činidla - , , , , secondary prevention of atherothrombotic events, , clopidogrel is indicated in: , - adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease. , - adult patients suffering from acute coronary syndrome:, - non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa). , - st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapy. , , in patients with moderate to high-risk transient ischaemic attack (tia) or minor ischaemic stroke (is), clopidogrel in combination with asa is indicated in:, - adult patients with moderate to high-risk tia (abcd2 score ≥4) or minor is (nihss ≤3) within 24 hours of either the tia or is event. , , prevention of atherothrombotic and thromboembolic events in atrial fibrillation, in adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for treatment with vitamin k antagonists (vka) and who have a low bleeding risk, clopidogrel is indicated in combination with asa for the prevention of atherothrombotic and thromboembolic events, including stroke. , , for further information please refer to section 5. , , ,.
rivastigmine 3m health care ltd
3m health care limited - rivastigminu - alzheimerova choroba - psychoanaleptics, , anticholinesterázy - symptomatická léčba mírné až středně těžké alzheimerovy demence.
aripiprazole accord healthcare 10mg tableta
accord healthcare polska sp. z o.o., varšava array - 14774 aripiprazol - tableta - 10mg - aripiprazol
aripiprazole accord healthcare 15mg tableta
accord healthcare polska sp. z o.o., varšava array - 14774 aripiprazol - tableta - 15mg - aripiprazol
m-iodbenzylguanidin (131i) ge healthcare 0,185-0,74gbq/ml injekční roztok
ge healthcare buchler gmbh & co. kg, braunschweig array - 13493 jobenguan-(131i)-hydrochlorid - injekční roztok - 0,185-0,74gbq/ml - jobenguan-(131i)